Methamphetamine-Related Disorders.

Dtsch Arztebl Int

*All of the authors of the S3 guideline are listed in eTable1. They contributed equally to this article; Landschaftsverband Rheinland (Rhineland Regional Council, LVR)-Klinik Köln; Psychotherapeutic Practice Bayreuth; Allgemeine Hospitalgesellschaft (AHG) Klinik Mecklenburg; University Medical Center Göttingen; Technische Universität Chemnitz; Department of Psychiatry and Psychotherapy, University Hospital of Regensburg.

Published: June 2017

Background: Methamphetamine is considered more dangerous than other stimulants because of its acute complications, long-term neurotoxicity, and potential for drug dependence. Until now, there have been no evidence-based guidelines for the treatment of methamphetamine-related disorders, either in Germany or abroad.

Methods: A systematic literature search was performed on the treatment of methamphetamine-related disorders. Based on this literature review, a multidisciplinary expert panel developed recommendations using the nominal group technique.

Results: The evidence base for the treatment of methamphetamine-related disorders is sparse. The efficacy of psychotherapeutic techniques such as cognitive behavioral therapy and contingency management and the efficacy of complex, disorder-specific treatment programs have been proven in ran - domized controlled trials, but it remains unclear which method is best. Persons carrying a diagnosis of substance abuse should be offered psychotherapy. Structured exercise programs, whether self-directed or professionally led, can improve addiction-specific endpoints as well as comorbid disorders and should, therefore, be offered as well. Pharmacotherapy has shown little to no effect in relatively low-quality clinical trials with low case numbers and high dropout rates, and therefore only a few weak recommendations were made. These include tranquilizers for the short-term treatment of agitation and atypical antipsychotics if necessary. Attempts to substitute other substances, such as methylphenidate or dexamphetamine, for methamphetamine have not yielded any robust evidence to date. Sertraline should not be administered due to serious adverse events.

Conclusion: Many of the recommendations in the guideline are made with a weak grade of recommendation because of the poor evidence base and the modest size of the reported therapeutic effects. In acute situations, symptomoriented treatment is recommended. Psychotherapy and exercise should be offered as well.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523799PMC
http://dx.doi.org/10.3238/arztebl.2017.0455DOI Listing

Publication Analysis

Top Keywords

methamphetamine-related disorders
16
treatment methamphetamine-related
12
evidence base
8
offered well
8
treatment
6
methamphetamine-related
4
disorders background
4
background methamphetamine
4
methamphetamine considered
4
considered dangerous
4

Similar Publications

Drug overdose deaths among women 1999-2021 in the United States: Differences by race, ethnicity, and age.

Womens Health (Lond)

December 2024

Department of Human Development and Family Studies and Family Studies, The Pennsylvania State University, University Park, PA, USA.

Background: The U.S. drug overdose epidemic is increasingly severe and steep increases have been seen among women.

View Article and Find Full Text PDF

Sex Differences in Methamphetamine Mortality in the United States: Heroin and Fentanyl Coinvolvement, 1999-2021.

Am J Prev Med

February 2025

Department of Health and Kinesiology, College of Applied Health Sciences, University of Illinois at Urbana-Champaign, Champaign, Illinois. Electronic address:

Article Synopsis
  • Methamphetamine-related deaths in the U.S. have surged since 1999, with a marked 58.8-fold increase for males and 65.3-fold for females, particularly between 2019 and 2021.
  • The analysis utilized CDC data to investigate trends in methamphetamine deaths, particularly focusing on the involvement of heroin and synthetic opioids like fentanyl.
  • Both male and female deaths involving methamphetamine increasingly included heroin or synthetic opioids, with proportions rising to 61.5% for males and 63.1% for females by 2021.
View Article and Find Full Text PDF
Article Synopsis
  • Individuals with problematic methamphetamine use demonstrate significant working memory difficulties compared to those without such use, as evidenced by lower performance scores on working memory tasks.
  • Brain imaging revealed that individuals using methamphetamine had altered neural responses in areas crucial for processing cognitive load, specifically showing increased activation in frontoparietal areas but decreased activation in default-mode areas during working memory tasks.
  • There is a strong correlation between activation in frontoparietal regions and individual working memory ability, suggesting that these brain responses could be a neural marker for the working memory challenges faced by chronic methamphetamine users.
View Article and Find Full Text PDF

20-year trends in Australian methamphetamine-related deaths, 2001-2020.

Int J Drug Policy

September 2024

School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia; Harm and Risk Reduction Program, Burnet Institute, Melbourne, Australia.

Article Synopsis
  • Over the past two decades, methamphetamine-related deaths in Australia have risen significantly, prompting a comprehensive analysis of mortality trends across various causes from 2001 to 2023.
  • The study found that nearly half of these deaths were due to unintentional drug toxicity, with other causes including self-harm and injuries, revealing fluctuating trends over time with periods of both increase and decrease in mortality rates.
  • The latest data indicate a slight rise in unintentional drug toxicity deaths, a stabilization in intentional self-harm rates, and continued growth in deaths attributed to natural causes like circulatory diseases.
View Article and Find Full Text PDF
Article Synopsis
  • Methamphetamine abuse is a global concern, with links established between stimulant use and risky sexual behaviors, but few studies have focused on the brain's functional changes in response to sexual and drug cues during abstinence periods.
  • In this study, researchers examined brain activity in 20 methamphetamine users after varying lengths of abstinence (short-term of 1 week to 3 months and long-term of 10 to 15 months), using a cue-reactivity task with methamphetamine, sexual, and neutral cues.
  • Results showed that long-term abstainers exhibited increased brain activation in areas related to sexual cues compared to other stimuli, implying that while brain function may recover somewhat over time, the combination of methamphetamine use and sexual urges poses significant
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!